Valganciclovir — Discount Pricing
Valganciclovir is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Valganciclovir Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $180.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Valganciclovir
Valganciclovir is a prescription medication. Ask your doctor if Valganciclovir is right for you.
How to Check Valganciclovir Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Valganciclovir at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Infections
What Valganciclovir is approved for (FDA label)
Valganciclovir tablet is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for: Adult Patients (1.1) Treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). Prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk.
Source: Read the full FDA label on DailyMed. Label effective date: June 24, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Boxed warning for Valganciclovir (FDA label)
WARNING: HEMATOLOGIC TOXICITY, IMPAIRMENT OF FERTILITY, FETAL TOXICITY, MUTAGENESIS AND CARCINOGENESIS WARNING: HEMATOLOGIC TOXICITY, IMPAIRMENT OF FERTILITY, FETAL TOXICITY, MUTAGENESIS AND CARCINOGENESIS Hematologic Toxicity: Severe leukopenia, neutropenia, anemia, thrombocytopenia, pancytopenia, and bone marrow failure including aplastic anemia have been reported in patients treated with valganciclovir [see Warnings and Precautions (5.1) ]. Impairment of Fertility: Based on animal data, and limited human data, valganciclovir may cause temporary or permanent inhibition of spermatogenesis in males and suppression of fertility in females [see Warnings and Precautions (5.3) ]. Fetal Toxicity: Based on animal data, valganciclovir has the potential to cause birth defects in humans [see Warnings and Precautions (5.4) ]. Mutagenesis and Carcinogenesis: Based on animal data, valganciclovir has the potential to cause cancers in humans [see Warnings and Precautions (5.5) ]. WARNING: HEMATOLOGIC TOXICITY, IMPAIRMENT OF FERTILITY, FETAL TOXICITY, MUTAGENESIS AND CARCINOGENESIS See full prescribing information for complete boxed warning . Hematologic Toxicity: Severe leukopenia, neutropenia, anemia, thrombocytopenia, pancytopenia, and bone marrow failure including aplastic anemia have been reported in patients treated with valganciclovir (5.1) . Impairment of Fertility: Based on animal data, and limited human data, valganciclovir may cause temporary or permanent inhibition of spermatogenesis in males and suppression of fertility in females. (5.3) Fetal Toxicity: Based on animal data, valganciclovir has the potential to cause birth defects in humans. (5.4) Mutagenesis and Carcinogenesis: Based on animal data, valganciclovir has the potential to cause cancers in humans. (5.5)
Source: FDA prescribing information (DailyMed). Set ID: 4db6dd63-e56b-45a4-86b2-ee125a1854a0. SPL document ID: 55015e34-52fc-0309-e063-6394a90af0f9. Label effective date: June 24, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Dosage forms and strengths for Valganciclovir (FDA label)
Valganciclovir Tablets, USP 450 mg are pink colored, oval shaped, film coated tablets debossed with ‘RDY’ on one side and ‘762’ on other side. Tablets: 450 mg (3)
Source: FDA prescribing information (DailyMed). Set ID: 4db6dd63-e56b-45a4-86b2-ee125a1854a0. SPL document ID: 55015e34-52fc-0309-e063-6394a90af0f9. Label effective date: June 24, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Valganciclovir (FDA label)
The following serious adverse reactions are discussed in greater detail in other sections of the labeling: Hematologic Toxicity [see Warnings and Precautions (5.1) ]. Acute Renal Failure [see Warnings and Precautions (5.2) ]. Impairment of Fertility [see Warnings and Precautions (5.3) ]. Fetal Toxicity [see Warnings and Precautions (5.4) ]. Mutagenesis and Carcinogenesis [see Warnings and Precautions (5.5) ]. The most common adverse reactions and laboratory abnormalities reported in at least one indication by greater than or equal to 20% of adult patients treated with valganciclovir tablets are diarrhea, pyrexia, fatigue, nausea, tremor, neutropenia, anemia, leukopenia, thrombocytopenia, headache, insomnia, urinary tract infection, and vomiting.
Source: FDA prescribing information (DailyMed). Set ID: 4db6dd63-e56b-45a4-86b2-ee125a1854a0. SPL document ID: 55015e34-52fc-0309-e063-6394a90af0f9. Label effective date: June 24, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Valganciclovir (FDA label)
Valganciclovir is contraindicated in patients who have had a demonstrated clinically significant hypersensitivity reaction (e.g., anaphylaxis) to valganciclovir, ganciclovir, or any component of the formulation [see Adverse Reactions (6.1) ]. Hypersensitivity to valganciclovir or ganciclovir (4)
Source: FDA prescribing information (DailyMed). Set ID: 4db6dd63-e56b-45a4-86b2-ee125a1854a0. SPL document ID: 55015e34-52fc-0309-e063-6394a90af0f9. Label effective date: June 24, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.